Navigation Links
gloStream Success Guarantee Ensures Doctors Will Be Back to Full Patient Load in as Little as 15 Days After EMR Implementation Completion
Date:1/25/2011

TROY, Mich., Jan. 25, 2011 /PRNewswire/ -- gloStream, maker of gloEMR, gloPM and gloSuite – the only electronic medical record   (EMR) and practice management (PM) software with Microsoft Office built right in – today launched the gloStream 15-Day Success Guarantee. This money-back guarantee ensures that doctors will be back up to their full patient load within 15 days of their implementation completion date or gloStream will provide a full refund for all gloStream software and services purchased.

"Because gloEMR is built with ease-of-use and flexibility in mind and our Partners – who deliver and support our products locally – use an innovative implementation process that's personalized to each practice's workflow, ramp up times are significantly reduced," said Mike Sappington, gloStream's CEO. "It also means that gloStream clients reach higher productivity and efficiency levels so they can provide better care while simultaneously ensuring their business success."

Industry wide, many doctors are fearful that implementing an EMR system will force them to see fewer patients and make less money. According to a recent CDW Healthcare study, nearly 40 percent of respondents believed patient encounters would drop at least 25 percent in their first year after EMR implementation leading to revenue losses of more than $100,000. This is a prime reason that gloStream developed the 15 Day Success Guarantee – to provide doctors with an option they can have confidence in and trust will keep their businesses going strong.

gloStream clients who have gone through a gloEMR implementation are able to see, first hand, why gloStream is able to offer the industry's first and only success guarantee.  "Our experience implementing gloEMR was extraordinarily positive," said Sue Messer, Practice Manager for Downriver Obstetrics and Gynecology in Trenton, Michigan. "Within just five days we were up to full capacity which has made a huge difference for our patients and our practice."

Doctors seeking more information about gloStream's 15-day Success Guarantee should visit www.glostream.com. Doctors who wish to have a gloStream team member contact them about the Guarantee should first complete the form at www.glostream.com/emrsuccessguarantee.

About gloStream

gloStream provides physicians with certified, voice-enabled electronic medical record and practice management solutions delivered and supported through a nationwide community of local technology Partners. gloStream products are secure, easy-to-use applications and the only solutions on the market with Microsoft Office built right in. gloStream Partners leverage gloDNA ("gloStream Detailed Needs Analysis"), a proprietary implementation process that has given gloStream a 100 percent success rate. Every practice that has implemented a gloStream application using the gloDNA process continues using it successfully today. For more information, visit glostream.com or call 877-456-3671.

gloEMR 6.0 from gloStream (CC-1112-501340-1), a complete EHR, is ONC-ATCB 2011/2012 compliant and has been certified by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable certification criteria for eligible providers adopted by the Secretary of Health and Human Services. gloEMR was certified on Sept 30, 2010, and has been certified for the following clinical quality measures: NQF 0421, NQF 0013, NQF 0028, NQF 0041, NQF 0024, NQF 0038, NQF 004, NQF, 0012, NQF 0032. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments.


'/>"/>
SOURCE gloStream
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. gloStream Announces Release of Microsoft-Based, Meaningful Use Certified gloEMR 6.0
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
8. EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407
9. Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury
10. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
11. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... and Webcast to Follow Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... the fourth quarter of 2016 on Wednesday, February 15, 2017, after ... ... on Wednesday, February 15, 2017, during which management will discuss the ... activities. To participate in the conference call, please dial 1-888-771-4371 (domestic) ...
(Date:1/19/2017)... , Jan. 19, 2017 This report ... current and future scenario of the global market. Large ... opioid consumption. Severe chronic constipation is a major side ... traditional laxatives. Hence, novel targeted therapy has been prescribed ... sufferers, launch of targeted medicines, and growing awareness about ...
(Date:1/19/2017)... BioTherapeutics Inc. ( Stealth ), a clinical-stage biopharmaceutical company ... additions to its senior leadership team: W. Douglas ... Daniel Geffken as interim Chief Financial Officer. In ... has been promoted to Chief Clinical Development Officer. ... Daniel to our management team, as both will be ...
Breaking Medicine Technology:
(Date:1/20/2017)... NY (PRWEB) , ... January 20, 2017 , ... ... VW+ 001 and its sugar-free alternative VW+ 002. The drinks have been produced ... with optimal conditions to perform during your workout. , After a successful launch ...
(Date:1/20/2017)... ... January 20, 2017 , ... “I Forgive You”: a fine examination of how God ... is the creation of published author, Stephen Miller, who, for over ten long years has ... to him. Born in Trinidad and Tobago, he has been serving the Lord for over ...
(Date:1/20/2017)... ... , ... “Knowledge is God’s Lighthouse”: a moving and colorful collection of ... the creation of published author, Gene Gaapf, a retired truck driver, and a long-time ... been writing since high school and have many different titles,” Gaapf mentions about his ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Management System: an On-demand E-learning system for Clinical and Regulatory education for ... is based on Aerolib`s successful education methodology of Disease Specific Documentation Improvement. ...
(Date:1/19/2017)... ... 19, 2017 , ... This month, the CEO and Clinical Director of Sober ... rehab center in Delray Beach, Florida has been changed from Sober Living Outpatient to ... Philip Seymour Hoffman and Chris Farley are dying from heroin overdoses, but thousands of ...
Breaking Medicine News(10 mins):